News - MedTech & Diagnostics
Cardinal Health international leader emphasises enhanced customer value through new go-to-market model

MedTech & Diagnostics News: In an exclusive interview with Health Industry Hub, Jorge Sahlieh, President of International Medical Products and Distribution at Cardinal Health, delved into his two-decade-long journey in the healthcare, medical devices, and fast-moving consumer goods (FMCG) sectors, and the key milestones that have shaped his journey within the Cardinal Health.
The conversation then turned to the critical challenges and complexities that the healthcare ecosystem faces today. In his role, Mr Sahlieh underscored the significance of customer centricity, both in terms of patients and healthcare professionals (HCPs), in addressing these challenges. Reimagining healthcare is a paramount goal for the industry, and the discussion expanded to the role of medtech companies like Cardinal Health in forging a path toward equitable access to healthcare services.
Over the last year, Cardinal Health has embarked on a transformative journey to enhance its operations guided by the principles of “focus and simplicity.” The interview delved into how this transformation is aligning with the evolving needs of the business and healthcare providers, ensuring streamlined operations and enhanced service delivery.
Looking ahead, Mr Sahlieh explored the top trends shaping the future of the medtech sector and how Cardinal Health is strategically aligning its business to thrive in this dynamic ecosystem. He offered valuable insights into the company’s forward-looking strategies and its commitment to staying at the forefront of the medtech industry.
In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News - MedTech & Diagnostics
Roche unlocks new horizons for genomic research in Asia Pacific
Roche is advancing its next-generation sequencing (NGS) ambitions in Asia Pacific following the global launch of AXELIOS 1 in June […]
MoreNews - Pharmaceuticals
‘Unexpected and surprising’: Novartis Lp(a) setback raises tough questions for Amgen and Lilly
The failure of Novartis’ lipoprotein(a) [Lp(a)] therapy to translate substantial biomarker reductions into meaningful cardiovascular benefits has been met with […]
MoreNews - MedTech & Diagnostics
More public hospitals turn to same-day hip and knee surgery, but key blind spots persist
Same-day hip and knee replacements to ease surgical waiting lists are being trialled at The Royal Adelaide Hospital (RAH), but […]
MoreNews - Pharmaceuticals
TGA approves oral Wegovy, prompting questions over efficacy and clinical positioning
The Therapeutic Goods Administration (TGA) approval of Novo Nordisk’s oral GLP-1 receptor agonist Wegovy (semaglutide) is introducing a new dimension to […]
More